Improved foam for varicose veins found to be safe in preliminary results from phase II trial

A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial. The results are being presented today (March 17) in Washington, D.C., at the annual scientific meeting of the Society of Interventional Radiology (SIR).

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news124945989.html">Improved foam for varicose veins found to be safe in preliminary results from phase II trial</a></p> <p>A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial. The results are being presented today (March 17) in Washington, D.C., at the annual scientific meeting of the Society of Interventional Radiology (SIR).</p>